LENZ Therapeutics's total assets for Q2 2025 were $217.33M, an increase of 7.99% from the previous quarter. LENZ total liabilities were $10.97M for the fiscal quarter, a 18.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.